Ligand to Report Third Quarter 2018 Results on November 8th

Go back to Ligand to Report Third Quarter 2018 Results on November 8th
LIGAND PHARMA (NASDAQ: LGND) Delayed: 287.38 -3.33 (1.15%)
Previous Close $290.71    52 Week High $139.79 
Open $289.11    52 Week Low $82.07 
Day High $293.37    P/E 668.33 
Day Low $284.87    EPS $0.43 
Volume 107,782